Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM131B Inhibitors

FAM131B inhibitors encompass a specialized class of chemical compounds tailored to impede the function of the FAM131B protein, which is encoded by the FAM131B gene. The FAM131B protein is implicated in various cellular processes, and its inhibitors operate through a diverse range of mechanisms to achieve functional suppression. These compounds target the signaling pathways and molecular interactions that FAM131B is involved in, rather than the gene expression or protein synthesis mechanisms. The specificity of these inhibitors allows for the precise modulation of FAM131B activity within the cell, ensuring that the downstream effects are a direct consequence of altered FAM131B function. The chemical structure and properties of FAM131B inhibitors are designed to interact with the protein's active sites or the regulatory domains that govern its activity. By binding to these critical regions, the inhibitors can thwart the protein's ability to participate in its normal cellular roles, which may include signal transduction, interaction with other proteins, or maintaining cellular structure integrity.

The impact of FAM131B inhibitors on the protein function is nuanced and depends on the specific chemical interactions they engage in. Some compounds might directly block the active site, rendering the protein unable to perform its catalytic or binding functions. Others may bind allosterically, altering the protein's conformation and preventing it from interacting with its usual partners or substrates. The inhibition process is a finely tuned event that results from the inhibitor's affinity for FAM131B and its ability to compete with natural substrates or cofactors for binding sites. These processes all lead to a decrease in the functional activity of FAM131B, ultimately influencing the cellular pathways in which the protein is a key player. The comprehensive understanding of the molecular basis of FAM131B action and its interaction with these inhibitors sheds light on the intricate web of cellular signaling and regulatory mechanisms. By dissecting these interactions, a clearer picture emerges of how cells maintain homeostasis and how the disruption of a single protein's function can have cascading effects on cell biology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Palbociclib is a CDK4/6 inhibitor that would impede the cell cycle, potentially reducing the expression of FAM131B by limiting the progression of the cell cycle where FAM131B might be involved.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Trametinib is a MEK inhibitor that disrupts the MAPK/ERK pathway, which could downregulate FAM131B expression if FAM131B is regulated by this pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can attenuate the PI3K/AKT/mTOR pathway, leading to reduced protein synthesis and potentially decreased levels of FAM131B if its expression is regulated by this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which is a central regulator of cell growth and proliferation, potentially decreasing the expression of FAM131B if it is involved in these processes.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib is a tyrosine kinase inhibitor with activity against RAF kinases, which could lead to reduced activity of the MAPK pathway and subsequent downregulation of FAM131B if it is associated with this signaling cascade.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor, which can lead to the accumulation of misfolded proteins and cellular stress, potentially affecting the stability and levels of FAM131B.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Nutlin-3 disrupts the interaction between p53 and MDM2, leading to the activation of p53 and its downstream pathways which could include the downregulation of FAM131B if it is negatively regulated by p53.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib is an EGFR inhibitor that may impact signaling pathways regulating the expression or function of FAM131B if it is downstream of EGFR signaling.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

Venetoclax is a BCL-2 inhibitor that can initiate apoptosis, potentially decreasing the levels of FAM131B if it has anti-apoptotic functions.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 is a BET bromodomain inhibitor that can modulate gene expression, potentially leading to the downregulation of FAM131B if its expression is controlled by BET-associated transcription factors.